Use of proton pump inhibitors during pregnancy and breastfeeding

Canadian Family Physician

Volumn 52, Issue 7, 2006, Pages 853-854

  Nava Ocampo, Alejandro A ^a,b   Velázquez Armenta, Elvia Y ^a,b   Han, Jung Yeol ^c   Koren, Gideon ^a,b,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Motherisk Program   (Canada)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CISAPRIDE; ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

BIRTH DEFECT; BREAST FEEDING; CESAREAN SECTION; CLINICAL TRIAL; CONGENITAL MALFORMATION; DIET THERAPY; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG FATALITY; DRUG MILK LEVEL; DRUG SAFETY; DRUG STABILITY; FETUS DISEASE; FETUS MALFORMATION; GASTROESOPHAGEAL REFLUX; HIGH RISK PREGNANCY; HUMAN; LIFESTYLE; PEPTIC ULCER; PERINATAL DEATH; PREGNANCY; PREMATURE LABOR; SHORT SURVEY; SPONTANEOUS ABORTION; TERATOGENESIS;

ANTI-ULCER AGENTS; BREAST FEEDING; DRUG TOXICITY; FEMALE; GASTROESOPHAGEAL REFLUX; H(+)-K(+)-EXCHANGING ATPASE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 33748808711     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. Raghunath AS, O'Morain C, McLoughlin RC. Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 2005;22(Suppl 1):55-63.
2. Richter JE. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am 2003;32:235-61.
3. Lalkin A, Loebstein R, Addis A, Ramezani-Namin F, Mastroiacovo P, Mazzone T, et al. The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am J Obstet Gynecol 1998;179:727-30.
4. Nikfar S, Abdollahi M, Moretti ME, Magee LA, Koren G. Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Dig Dis Sci 2002;47:1526-9.
5. Kallen BA. Use of omeprazole during pregnancy - no hazard demonstrated in 955 infants exposed during pregnancy. Eur J Obstet Gynecol Reprod Biol 2001;96:63-8.
6. Diav-Citrin O, Arnon J, Shechtman S, Schaefer C, van Tonningen MR, Clementi M, et al. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther 2005;21:269-75.
7. Marshall JK, Thompson AB, Armstrong D. Omeprazole for refractory gastroesophageal reflux disease during pregnancy and lactation. Can J Gastroenterol 1998;12:225-7.
8. Plante L, Ferron GM, Unruh M, Mayer PR. Excretion of pantoprazole in human breast milk. J Reprod Med 2004;49:825-7.
9. Wilton LV, Pearce GL, Martin RM, Mackay FJ, Mann RD. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol 1998;105:882-9.